Customize your JAMA Network experience by selecting one or more topics from the list below.
As I reflect back on 2019 here at JAMA Neurology, I want to pause and thank all of our editors, editorial board, peer reviewers,1 authors, and readers for all they have done for the journal over the past 12 months. For those of us on the editorial team, stewarding this journal remains both an absolute joy and a privilege, and we realize just how much all of your contributions and support are crucial to our success. The year has once again been record setting for the number of manuscripts received (2466; Table2-4), and the quality of the more than 1700 research manuscripts sent for consideration has never been higher.
While some of our growth may again may be linked to an increase in impact factor to 12.3, I am convinced that it mainly reflects a continued transformation of the journal into one that emphasizes publishing a very diverse set of articles that cover the breadth of neurological conditions across our research, opinion, and education sections. The number of clinical trial submissions has sharply increased once again this past year, and the impact and diversity of these trials has truly been remarkable, as pointed out recently in an Editorial by Kamel and Dubal.5
The journal remains highly selective, with an overall acceptance rate of 10% (8% for research manuscripts), but our editors and reviewers worked extremely hard this year to further improve on our already excellent response times. We continue to rapidly respond to authors, with a median receipt to first decision of 4 days without peer review and a 14-day peer review turnaround; our acceptance to publication and receipt to publication median times decreased by 1 week and 5 weeks, respectively.
We continue to feel strongly that the impact factor is but 1 measure of any journal’s success. Publishing in JAMA Neurology is attractive to many authors because of our numerous press releases, rapid online publication, and the use of social media to further highlight and increase the visibility of our articles, many of which have extremely high Altmetric scores.2-4 In 2019, 4.8 million full-text views and PDF downloads of articles occurred on our website (a record), and important and concise information was disseminated nearly daily to our more than 79 000 followers on Twitter (@JAMANeuro) and Facebook. The monthly print editions of our journal are widely read, but our weekly Monday morning online content offerings, distributed via our website as well as to the more than 54 000 individuals who receive our electronic table of contents, have increasingly emerged as the face of JAMA Neurology.
The journal continues to evolve, mainly in response to your helpful suggestions. We have continued to diversify our offerings, including expanding education and opinion sections while accepting articles from a wide range of authors that cover the full spectrum of neurologic subspecialties in this exciting time of increased understanding and better treatment of the conditions for which we all care so deeply. The journal is run by an amazing group of more than 2 dozen individuals, including dedicated deputy and associate editors who work with an outstanding editorial board whose mission remains to continue to improve the journal each and every year. We thank and acknowledge the contributions, reviews, and guidance of our editorial board members who stepped down at the end of 2019, including Louis R. Caplan, MD, Vladimir Hachinski, MD, DSc, and Michael K. Racke, MD. Our Editorial Manager Kate Denevan remains the heart and soul of JAMA Neurology, and her tireless efforts and communication with authors and reviewers form the backbone of support that makes the journal thrive.
We remain quite humbled that readers and authors continue to look to JAMA Neurology as a useful and important home for neurologic research, education, and opinion. There are many choices of outstanding journals in our field, and we certainly do not take the fact that you choose ours lightly. As I have done every year, I want to again remind everyone that JAMA Neurology is your journal, not ours, and we would appreciate any comments or suggestions you might have as we continue to evolve to better serve your needs. From all of us at JAMA Neurology, thank you once again for a great 2019, and we look forward with great enthusiasm to what 2020 has in store.
Corresponding Author: S. Andrew Josephson, MD, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 (firstname.lastname@example.org).
Published Online: March 23, 2020. doi:10.1001/jamaneurol.2020.0240
Conflict of Interest Disclosures: None reported.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Josephson SA. JAMA Neurology—The Year in Review, 2019. JAMA Neurol. 2020;77(5):547–548. doi:10.1001/jamaneurol.2020.0240
Coronavirus Resource Center
Create a personal account or sign in to: